Ionis Pharmaceuticals, Inc. (IONS)

Ionis Pharmaceuticals Statistics

Total Valuation

IONS has a market cap or net worth of $6.86 billion. The enterprise value is $6.53 billion.

Market Cap	6.86B
Enterprise Value	6.53B

Important Dates

The last earnings date was Wednesday, July 30, 2025, before market open.

Earnings Date	Jul 30, 2025
Ex-Dividend Date	n/a

Share Statistics

IONS has 159.39 million shares outstanding. The number of shares has increased by 7.89% in one year.

Current Share Class	159.39M
Shares Outstanding	159.39M
Shares Change (YoY)	+7.89%
Shares Change (QoQ)	+14.66%
Owned by Insiders (%)	0.86%
Owned by Institutions (%)	104.84%
Float	157.72M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	7.12
Forward PS	9.40
PB Ratio	10.84
P/TBV Ratio	10.85
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	6.92
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 2.87, with a Debt / Equity ratio of 3.10.

Current Ratio	2.87
Quick Ratio	2.61
Debt / Equity	3.10
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-2.92

Financial Efficiency

Return on equity (ROE) is -59.82% and return on invested capital (ROIC) is -6.89%.

Return on Equity (ROE)	-59.82%
Return on Assets (ROA)	-5.88%
Return on Invested Capital (ROIC)	-6.89%
Return on Capital Employed (ROCE)	-12.79%
Revenue Per Employee	$883,197
Profits Per Employee	-$250,605
Employee Count	1,069
Asset Turnover	0.33
Inventory Turnover	n/a

Taxes

Income Tax	-6.17M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -13.00% in the last 52 weeks. The beta is 0.25, so IONS's price volatility has been lower than the market average.

Beta (5Y)	0.25
52-Week Price Change	-13.00%
50-Day Moving Average	38.81
200-Day Moving Average	35.06
Relative Strength Index (RSI)	61.35
Average Volume (20 Days)	1,867,593

Short Selling Information

The latest short interest is 12.89 million, so 8.09% of the outstanding shares have been sold short.

Short Interest	12.89M
Short Previous Month	14.14M
Short % of Shares Out	8.09%
Short % of Float	8.17%
Short Ratio (days to cover)	6.13

Income Statement

In the last 12 months, IONS had revenue of $944.14 million and -$267.90 million in losses. Loss per share was -$1.72.

Revenue	944.14M
Gross Profit	49.39M
Operating Income	-267.08M
Pretax Income	-352.50M
Net Income	-267.90M
EBITDA	-255.78M
EBIT	-267.08M
Loss Per Share	-$1.72

Balance Sheet

The company has $2.29 billion in cash and $1.96 billion in debt, giving a net cash position of $329.00 million or $2.06 per share.

Cash & Cash Equivalents	2.29B
Total Debt	1.96B
Net Cash	329.00M
Net Cash Per Share	$2.06
Equity (Book Value)	632.00M
Book Value Per Share	3.97
Working Capital	1.68B

Cash Flow

Operating Cash Flow	n/a
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross margin is 5.23%, with operating and profit margins of -28.29% and -28.37%.

Gross Margin	5.23%
Operating Margin	-28.29%
Pretax Margin	-29.03%
Profit Margin	-28.37%
EBITDA Margin	-27.09%
EBIT Margin	-28.29%
FCF Margin	n/a

Dividends & Yields

IONS does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-7.89%
Shareholder Yield	-7.89%
Earnings Yield	-3.91%
FCF Yield	n/a

Analyst Forecast

The average price target for IONS is $57.79, which is 34.30% higher than the current price. The consensus rating is "Buy".

Price Target	$57.79
Price Target Difference	34.30%
Analyst Consensus	Buy
Analyst Count	14
Revenue Growth Forecast (5Y)	26.26%
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	3